2013, Number 3
<< Back Next >>
Rev Cubana Pediatr 2013; 85 (3)
Urolithiasis in the child
Durán ÁS
Language: Spanish
References: 44
Page:
PDF size: 105.92 Kb.
ABSTRACT
Urinary tract litiasis is a condition that is generally associated to metabolic impairments
such as hypercalciuria, hypocitraturia, hyperphosphaturia, hyperuricosuria,
hyperoxaluria, cystinuria and urinary acidification defect. However the true etiology of
the disease is multifactoral and its formation involves genetic predisposition and
environmental factors among which diet and low fluid intake contribute to the
formation of calculi. The genetic and anatomic causes are the main factors in children
and adolescents. Idiopathic hypercalciuria is the most frequent cause in these age
groups, although as it occurs in the adult, the environmental factors (diet salt, protein,
calcium and other nutrient intake) may be important for the disease. Among the local
factors of the urine that may favor the formation of calculi are low urinary volume, low
urinary pH, urinary retention and infections. This review briefly analyzed the various
causes of lithiasis and assessed the importance of adequate fluid intake, the changes
in diet that can be made according to the type of lithiasis, the different therapeutic
actions that should be taken in case of lithiasis-caused renal colic, asymptomatic cases
with proven lithiasis and in those cases in which lithiasis may obstruct urinary flow.
REFERENCES
Restrepo de Rovetto C, de Castaño I, Carvajal Duque D. Urolitiasis en niños, una patología en aumento. Programa de Educación Continua en Pediatría. Sociedad Colombiana de Pediatría. Volumen 8. Número 5. Bogotá: Editorial Legis; 2009. p. 46- 63.
Stamatelou ME, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23.
Frick KK, Bushinsky DA. Molecular mechanisms of primary hipercalciuria. J Am Soc Nephrol. 2003;14:1082-95.
Cohen TD, Ehreth J, King LR, Preminger GM. Pediatric urolithiasis: medical and surgical management. Urology. 1996;47:292-303.
Kroovand RL. Pediatric urolithiasis. Urol Clin North Am. 1997;24:173-84.
Robertson WG, Peacock M, Marshall RW, Speed R, Nordin BE. Seasonal variations in the composition of urine in relation to calcium-stone formation. Clin Sci Mol Med. 1975;49:597-602.
Parry ES, Lister IS. Sunlight and hipercalciuria. Lancet. 1975;1:1063-5.
Moe EW, Bonny O. Genetic hipercalciuria. J Am Soc Nephrol. 2005;16:729-45.
Stechman MJ, Nellie Y, Loh NY, Rajesh V. Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol. 2009;24:2321-32.
Labrada Rodríguez MV, Larrea Masvidal E, Castillo Rodríguez M, Borrero Barriento LL, Valdés Gómez AC. Tratamiento de la litiasis renoureteral con litotricia extracorpórea por ondas de choque: experiencia en Cuba. Rev Cubana Pediatr [serie en Internet]. 2012 [citado 2 de septiembre de 2012];84(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312012000200002&lng=es&nrm=iso&tlng=es
Curhan GC, Willet WC, Rimn EB, Stampfer MJ. A prospective study of dietary calcium and others nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328: 833-8.
Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999; 81(suppl 1):26- 30.
Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011;80:1278-91.
Bastug F, Düsünsel R. Pediatric urolithiasis: causating factors, diagnosis and medical management. Nat Rev Urol. 2012;9:138-46.
Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl Med. 1979;300:337-40.
Reed BY, Heller HJ, Gotimer WL, Pak CY. Mapping a gene defect in absortive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab. 1999;84:3907-13.
Aladjem M, Baar J, Lahat E, Bistritzer T. Renal and absortive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression. Pediatrics. 1996;97:216-9.
Croppi F, Taddei L, Brandi ML, Croppi E. Idiopathic hypercalciuria and calcium renal stone disease: our cases. Clin Cases Miner Bone Metab. 2009;6:251-3.
Stapleton FB, Smith J. Hypercalciuria. En: Zelikovic I, Eisenstein I (eds). Practical Algorithms in Pediatric Nephrology. Basel: Karger; 2008. p. 102-3.
Worcester EM, Coe FC. New insights into pathogenesis of idiopathic hypercalciuria. Sem Nephrol. 2008;28:120-32.
Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr. 2009;21:214-9.
Kher KK, Schnaper HW, Makker SP. Clinic pediatric nephrology. 2nd ed. Abingdon: Informa, UK Ltd; 2007. p. 539-51.
Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calcul. Eur Urol. 1993;24:172-6.
Moe OW, Pearle MS, Sakhaee K. Pharmacotherapy for urolithiasis: evidence for clinical trials. Kidney Int. 2011;79:385-92.
Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology. 2005;66:712-5.
Alon US. Medical treatment of pediatric urolithiasis. Pediatr Nephrol. 2009;24:2129-35.
Miller LA, Stapleton FB. Urinary volume in children with urolithiasis. J Urol. 1989;141:918-20.
Lande MB, Varade W, Erkan E, Niederbracht Y, Schwartz GJ. Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol. 2005;20:491-4.
Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Borghi C. Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab. 2008;5:135-41.
Frassetto LA, Nash E, Morris RC, Sebastian A. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion. Kidney Int. 2000;58:748-52.
Jiang J, Knight J. Easter LH, Neiberg R, Holmes RP, Assimos DG. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol. 2011;186:135-9.
Kaufman DW, Kelly JP, Curhan GC, Anderson T, Dretter SP, Preminger GM, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008;19:1197-203.
Goodyer P, Saadi I, Ong P, Elkas G, Rozen R. Cystinuria subtype and risk of nephrolithiasis. Kidney Int. 1998;54:56-61.
Alon US, Srivastava T. Urolithiasis. En: Kher KK, Schnaper WH, Makker SP, (eds). Clinical Practice Nephrology. 2nd. edition. London: Informa; 2007. p. 539-52.
Milliner DS. Cystinuria. Endocrinol Metabol Clin North Am. 1990;19:889-907.
De Berardinis RJ, Coughlin CR, Kaplan P. Penicillamine therapy in pediatric cystinuria. Experience from a cohort of American children. J Urol. 2008;180:2620-3.
Pavitra S, Rao S, Vishal G, Pai GS. D-penicillamine induced elastosis perforans serpiginosa mimicking acne keloidalis nuchae. Indian J Dermatol. 2011;56:449-50.
Narendra A, White M, Rolton H, Allou BZ, Wilkinson G, McColl J, et L. Nephrocalcinosis in preterm babies. Arch Dis Child Fetal Neonatol Ed. 2001;85:F207- F213.
Wolfiel N. Haslam R, Le Quesle G, Chambers HM, Hogg R, Jureidini K. Ultrasound diagnosis of Nephrocalcinosis in preterm infants. Arch Dis Child. 1988;63:86-8.
Stojanovic V, Vijatov GD. Nephrolithiasis caused by ceftriaxone in a 3-year-old child with ureteropelvic junction obstruction. Case Report Med. 2009; Online may 26, doi: 10,1155/2009/365962 (PubMed).
Schaad UB, Wedgwood-Krucko J, Tschaepeller H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. The Lancet. 1988;332:1411-13.
de Moor RA, Egberts ACG, Schroder CH. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis. Eur J Pediatr. 1999;158:975-7.
Dulac Y, Bouissou F, Azema C, Baunin C, Normand-Gottis N. Anuria caused by urinary lithiasis induced by ceftriaxone in a 6-year-old child. Press Medicalle. 1995;24:916.
Devuyst O, Thakker RV. Dent's disease. Orphant J Rare Dis. 2010;5:28.